Regeneron Pharmaceuticals, Inc. is expected to report earnings.
REGN Earnings Date
2026-02-03
Fiscal Quarter Ending
Dec/2025
Consensus EPS Forecast
$8.06
EPS of Last Year
$9.90
Report Date of Last Year
2/04/2025
MarketCap
$81,589,764,898
Number of Analysts
6